{
    "clinical_study": {
        "@rank": "90843", 
        "arm_group": [
            {
                "arm_group_label": "24 hours mild therapeutic hypothermia", 
                "arm_group_type": "Active Comparator", 
                "description": "The patient will be treated with mild therapeutic hypothermia for 24 hours after reaching the target temperature between 32-34\u00b0C."
            }, 
            {
                "arm_group_label": "48 hours mild therapeutic hypothermia", 
                "arm_group_type": "Experimental", 
                "description": "The patient will be treated with mild therapeutic hypothermia for 48 hours after reaching the target temperature between 32-34\u00b0C."
            }
        ], 
        "brief_summary": {
            "textblock": "This PhD study is a sub study in a randomized clinical controlled multicenter trial named\n      \"TTH48\" (ClinicalTrials.gov Identifier: NCT01689077).\n\n      The TTH48 trial examines prolonged mild therapeutic hypothermia (\"MTH\") at 32-34\u00b0C in 24\n      versus 48 hours with the primary outcome Cerebral Performance Category after 6 month in\n      comatose out-of-hospital cardiac arrest patients.\n\n      THE OVERALL AIM OF THIS PhD STUDY IS TO INVESTIGATE THE CARDIAC FUNCTION AND THE\n      HEMODYNAMICS BY BIOCHEMICAL CARDIAC MARKERS, ECHOCARDIOGRAPHY, BY ANALYZING THE USAGE OF\n      INOTROPES/VASOPRESSORS AND BY ANALYZING ECG DATA FOR ARRHYTHMIAS IN THE 24 VERSUS 48 HOURS\n      MTH GROUPS."
        }, 
        "brief_title": "The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest", 
        "completion_date": {
            "#text": "March 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cardiac Arrest", 
            "Hypothermia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Heart Arrest", 
                "Hypothermia"
            ]
        }, 
        "detailed_description": {
            "textblock": "The PhD-study contains 3 sub studies:\n\n        -  Study 1 estimates the extend of myocardial damage resulting from the primary arrest and\n           from the reperfusion injuries: Area under the curve of cTnT and CK-MB as 12 repeated\n           measurements and NT-proBNP as 4 measurements post arrest\n\n           -Hypothesis: There is a statistically significantly greater release of the cardiac\n           biomarkers cTnT and NT-proBNP quantified by the area under the curve in the 24 versus\n           the 48 hours group in the intervention period from 24 to 72 hours.\n\n        -  Study 2  investigates MTH\u00b4s influence on systolic and diastolic function by standard\n           and Tissue Doppler (TDI) echocardiography after 24, 48 and 72 hours. The primary\n           endpoint is mitral annular systolic velocity (\"S\u00b4 max\")\n\n           -Primary hypothesis: There is statistically significant improvement in S' max from the\n           time T24 to T72 in the 48 versus the 24 hours group.\n\n           -Secondary hypothesis: There is statistically significantly better systolic function at\n           T48 measured in terms of individual S' max-change in the 48 hours group (still\n           hypothermic) versus the 24 hours group (reached normothermia).\n\n        -  Study 3 investigates MTH\u00b4s influence on the need for vasopressor or inotrope and the\n           duration of arrhythmias during the first 72 hours post arrest.\n\n             -  Primary hypothesis: There is a statistically significantly increased tendency of\n                arrhythmias in the 48 versus the 24 hours group measured in the period from T0 to\n                T72.\n\n             -  Secondary hypothesis: There is a statistically significantly reduced need for\n                inotropes in the 48 versus the 24 hours group measured by cumulative vasopressor\n                index in the period from T0 to T72."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Resuscitated after cardiac arrest outside hospital with suspected cardiac triggering\n             cause (and stabile circulation for at least 20 minutes after return of spontaneous\n             circulation,\n\n          2. Glasgow coma score < 8 and\n\n          3. Age \u2265 18 years and < 80 years.\n\n        Exclusion Criteria:\n\n          1. Cardiac arrest of suspected non-cardiac triggering cause (e.g. trauma, aortic\n             dissection, massive bleeding, hypoxia or accidental hypothermia),\n\n          2. >60 minutes from cardiac arrest to ROSC,\n\n          3. Time from cardiac arrest until start of cooling >4 hours,\n\n          4. Terminal illness,\n\n          5. Coagulopathy (medical anticoagulation treatment including thrombolysis is not a\n             contraindication),\n\n          6. Unwitnessed arrests with asystolia as presenting rhythm,\n\n          7. Pregnancy,\n\n          8. Persistent cardiogenic shock,\n\n          9. Systolic blood pressure <80 mmHg despite vasoactive treatment and intra-aortic\n             balloon pump\n\n         10. CPC 3-4 before the cardiac arrest,\n\n         11. Suspected/confirmed acute intra cerebral hemorrhage or stroke,\n\n         12. Acute CABG or other operation in connection with performing CPR,\n\n         13. Lack of consent from the relatives,\n\n         14. Lack of consent from the GP and\n\n         15. Lack of consent from the patient if he/she wakes up and is relevant."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 17, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02066753", 
            "org_study_id": "TTH48AG"
        }, 
        "intervention": {
            "arm_group_label": [
                "24 hours mild therapeutic hypothermia", 
                "48 hours mild therapeutic hypothermia"
            ], 
            "description": "Mild therapeutic hypothermia with a target temperature between 32-34\u00b0C.", 
            "intervention_name": "Mild therapeutic hypothermia", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Cardiac arrest", 
            "Therapeutic Hypothermia", 
            "Cardioprotectiveness", 
            "Hemodynamics"
        ], 
        "lastchanged_date": "February 19, 2014", 
        "link": {
            "description": "Link to the parent trial: TTH48", 
            "url": "http://www.tth48.com"
        }, 
        "location": [
            {
                "contact": {
                    "email": "anders.grejs@dadlnet.dk", 
                    "last_name": "Anders Grejs, MD", 
                    "phone": "+45 51948171"
                }, 
                "facility": {
                    "address": {
                        "city": "Aarhus N", 
                        "country": "Denmark", 
                        "state": "Central Denmark Region", 
                        "zip": "8200"
                    }, 
                    "name": "Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Skejby"
                }, 
                "investigator": [
                    {
                        "last_name": "Anders Grejs, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Hans Kirkegaard, Professor MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jakob Gjedsted, MD, PhD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Erik Sloth, Professor MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Jens F Lassen, MD, PhD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "eldar.soreide@sus.no", 
                    "last_name": "Eldar S\u00f8reide, Professor MD"
                }, 
                "facility": {
                    "address": {
                        "city": "Stavanger", 
                        "country": "Norway", 
                        "zip": "4068"
                    }, 
                    "name": "Research Center of Emergency Medicine and Department of Anesthesiology and Intensive Care Medicine, Stavanger University Hospital"
                }, 
                "investigator": [
                    {
                        "last_name": "Eldar S\u00f8reide, Professor MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Alf I Larsen, Professor MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Per D Hamre, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Kristian Strand, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Denmark", 
                "Norway"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "The Cardiac Effects of Prolonged Hypothermia After Cardiac Arrest", 
        "overall_contact": {
            "email": "anders.grejs@dadlnet.dk", 
            "last_name": "Anders Grejs, MD", 
            "phone": "+45 51948171"
        }, 
        "overall_official": {
            "affiliation": "Research Center of Emergency Medicine and Department of Anesthesiology and Intensive Care Medicine, Aarhus University Hospital, Skejby, Denmark", 
            "last_name": "Anders Grejs, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Denmark: The Regional Committee on Biomedical Research Ethics", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Allocated sub study 1", 
                "measure": "Area under the curve cTnT", 
                "safety_issue": "No", 
                "time_frame": "In the intervention period from 24 to 72 hours"
            }, 
            {
                "description": "Allocated sub study 2", 
                "measure": "Mitral annular systolic velocity", 
                "safety_issue": "No", 
                "time_frame": "After 24 hours, 48 hours and 72 hours"
            }, 
            {
                "description": "Allocated sub study 3", 
                "measure": "Duration of arrhythmias", 
                "safety_issue": "Yes", 
                "time_frame": "From target temperature (32-34\u00b0C) has been reached until 72 hours after"
            }, 
            {
                "description": "Allocated sub study 3", 
                "measure": "Cumulative vasopressor index", 
                "safety_issue": "No", 
                "time_frame": "From target temperature (32-34\u00b0C) has been reached until 72 hours after"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02066753"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Allocated sub study 1", 
            "measure": "Area under the curve NT-proBNP", 
            "safety_issue": "No", 
            "time_frame": "In the intervention period from 24 to 72 hours"
        }, 
        "source": "University of Aarhus", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Aarhus", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}